Illumina News and Research

RSS

Mining 25 years of data reveals new insights into predicting the age of onset for Huntington disease

Investigators at the University of British Columbia/Centre for Molecular Medicine & Therapeutics and BC Children's Hospital have examined more than 25 years of data to reveal new insights into predicting the age of onset for Huntington disease.

18 May 2019

IDT announces significant NGS portfolio expansion

Demonstrating its advocacy for genomics research, Integrated DNA Technologies announces a significant expansion to its NGS portfolio.

From Integrated DNA Technologies 10 May 2019

Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium

Arc Bio today launched its Galileo Pathogen Solution product line at the ASM Clinical Virology Symposium in Savannah.

From Arc Bio, LLC 2 May 2019

Treating cancer patients with personalized, combination therapies improves outcomes

Precision oncology often relies on treating patients with a single, molecularly matched therapy that targets one mutation in their tumor.

23 Apr 2019

Arc Bio launches unique NGS-based metagenomics platform for pathogen detection

Arc Bio today revealed the second offering in its Galileo product line: a comprehensive next-generation sequencing test for the monitoring of post-transplant patients.

12 Apr 2019

Study compares library preparation and sequencing platforms for single-cell RNA-sequencing

Researchers from University of Southern Denmark, Wellcome Sanger Institute and BGI, today published a study in the journal Genome Biology comparing the library preparation and sequencing platforms for single-cell RNA-sequencing.

9 Apr 2019

UMSOM's Institute for Genome Sciences receives $17.5 million grant for infectious disease research

The Institute for Genome Sciences at the University of Maryland School of Medicine was awarded $17.5 million from the National Institute of Allergy and Infectious Diseases to fund the IGS Genome Center for Infectious Diseases for another five years.

5 Apr 2019

AACR Annual Meeting 2019 Highlighted Latest Advances in Cancer Research

On Friday, March 29 to Wednesday, April 3, the Georgia World Congress Center in Atlanta, Georgia, hosted the AACR Annual Meeting 2019.

From 10x Genomics, Inc. 4 Apr 2019

ACROBiosystems opens new Innovation laboratory in Delaware

January 18, 2018, ACROBiosystems officially opened its New Innovation laboratory in the Delaware Innovation Space in Wilmington, Delaware, USA, and held a grand opening ceremony.

From ACROBiosystems 7 Mar 2019

Study finds new genetic clues associated with asthma in African ancestry populations

In the largest study of its kind, researchers at the University of Colorado Anschutz Medical Campus have found new clues into the parts of the human genome associated with the higher rates of asthma in those of African ancestry.

21 Feb 2019

Blood test helps identify distinct molecular signatures in children with cystic fibrosis

Researchers at Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago, and colleagues, used a blood test and microarray technology to identify distinct molecular signatures in children with cystic fibrosis.

12 Dec 2018

Avoidant grievers unconsciously monitor and block mind-wandering contents, study shows

People who are grieving a major loss, such as the death of a spouse or a child, use different coping mechanisms to carry on with their lives. Psychologists have been able to track different approaches, which can reflect different clinical outcomes.

11 Dec 2018

Illumina signs agreement to acquire Pacific Biosciences

Illumina, Inc. and Pacific Biosciences today announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction.

2 Nov 2018

MCG selected as designated laboratory for NCI-MATCH trial

The Georgia Esoteric and Molecular Laboratory at the Medical College of Georgia at Augusta University has been selected as a designated laboratory for the National Cancer Institute's Molecular Analysis for Therapy Choice, or MATCH trial, which is assessing the effectiveness of targeting cancer-causing gene changes rather than cancer type.

1 Nov 2018

Texas A&M and UTA establish Texas Genomics Core Alliance

Texas A&M University and The University of Texas at Arlington have established The Texas Genomics Core Alliance to increase access to and decrease costs of cutting-edge, high-throughput genomics sequencing technologies.

22 Oct 2018

Human Vaccines Project and Seqirus collaborate to accelerate universal flu vaccine research

The Human Vaccines Project, a nonprofit public-private partnership focused on decoding the immune system to improve human health, and Seqirus, a global leader in the prevention of influenza, announced today that Seqirus is joining the Project's Universal Influenza Vaccine Initiative.

28 Jun 2018

Rare variants in non-coding DNA inherited from parents heighten autism risk

In recent years, researchers have firmly established that gene mutations appearing for the first time, called de novo mutations, contribute to approximately one-third of cases of autism spectrum disorder.

20 Apr 2018

The Human Microbiome – A New Potential Fingerprint in Forensic Evidence?

Professor Jack Gilbert gives an overview of the Burglary Microbiome Project, which he discussed at Pittcon 2018.

From Pittcon 29 Mar 2018

Four genes associated with OCD identified

There are found genes that have been identified to be associated with obsessive compulsive disorder (OCD). These genes have been found to alter the circuitry of the brain in a manner that could lead to OCD. These genetic links also point to the fact why OCD sometimes runs in families. The study is published in the latest issue of Nature Communications.

18 Oct 2017

Illumina and Bio‑Rad introduce first next-generation sequencing solution for single-cell analysis

Illumina, Inc. and Bio‑Rad Laboratories, Inc. today announced the launch of the Illumina Bio-Rad Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference, San Francisco.

26 Jul 2017